Xueni Ma

机构：Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0001-9635-8370

发表论文 45 篇 · 总被引 377 次 · h-index 12

代表论文

• Nets in fibrosis: Bridging innate immunity and tissue remodeling (2024 · International Immunopharmacology · 被引 26)
• Sialylation in the gut: From mucosal protection to disease pathogenesis (2024 · Carbohydrate Polymers · 被引 25)
• Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway (2023 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 17)
• Antibiotics Resistance Prevalence of Helicobacter pylori Strains in Northwest China (2022 · Infection and Drug Resistance · 被引 17)
• SUMOylation at the crossroads of gut health: insights into physiology and pathology (2024 · Cell Communication and Signaling · 被引 15)
• Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway (2024 · International Immunopharmacology · 被引 14)